Researchers at Zaozhuang Maternal and Child Health Hospital in China explored acupuncture as a treatment option for female sexual dysfunction (FSD). The study, published in Sexual Medicine, offers insight into how traditional acupuncture may influence sexual health outcomes for women facing FSD. The investigation situates acupuncture as an accessible, nonpharmacological approach that could complement existing therapies, particularly for individuals seeking noninvasive methods with minimal risk. The findings contribute to a growing body of evidence suggesting that acupuncture may offer meaningful improvements in sexual function and wellbeing for women, reinforcing its role as a potential component of comprehensive care for FSD.
A retrospective analysis tracked 24 women with FSD who underwent acupuncture sessions between October 2018 and February 2022. Before and after the treatment, participants were assessed across several domains: sexual desire, arousal, satisfaction, frequency of orgasms, and pain during intercourse. The study design aimed to capture real-world outcomes in a clinical setting, offering a pragmatic view of how acupuncture could affect daily sexual experiences for patients. Across the cohort, measurements demonstrated notable changes that reflected improved sexual function and comfort during intimate moments, highlighting acupuncture as a practical option in routine healthcare for FSD.
According to the authors, the overall rate of improvement observed in the treatment group reached 100%, with clear distinctions between pre-treatment and post-treatment sexual lives. By the study’s end, participants reported higher satisfaction levels, increased orgasm frequency, and reduced pain during intercourse. The researchers emphasized that the approach is simple, widely available, and safe for overall health, suggesting acupuncture could become a valuable addition to standard care for FSD when used by trained practitioners and combined with individualized patient guidance. These results align with broader efforts to validate nonpharmacologic therapies that empower women to address sexual health concerns through accessible, evidence-informed options, and they underscore the importance of ongoing research to confirm long-term benefits and identify which patients may benefit most. [citation attributions where applicable]